⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of BiomeBank and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
BiomeBank
↗Adelaide, Australia
BiomeBank is a clinical-stage biotechnology company based in Adelaide, Australia, focused on developing microbiome-based therapies to restore gut microbial ecology and treat chronic diseases. The company utilizes its proprietary CONSORTIOME® platform, which integrates microbiology, machine learning, and bioinformatics to identify and develop next-generation, co-cultured microbial therapeutics.
In 2022, BiomeBank achieved a significant milestone by receiving regulatory approval from the Australian Therapeutic Goods Administration (TGA) for BIOMICTRA®, the world's first regulated donor-derived microbiome therapy for recurrent Clostridioides difficile infection. The company is currently advancing a pipeline of next-generation therapies for conditions including ulcerative colitis, while also expanding into consumer probiotic products in partnership with Blackmores.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Founded:2018
Ownership:private
Status:operating
FUNDING
Stage:Series B
Total Raised:$10.7M
Investors:Ellerston Capital, Artesian, The Hospital Research Foundation Group, Blackmores, South Australian Venture Capital Fund
PIPELINE
Stage:Clinical
Lead Drug Stage:Commercial (BIOMICTRA®)
Modalities:Microbiome Therapeutics, Live Biotherapeutic Products (LBPs), Fecal Microbiota Transplantation (FMT)
Active Trials:4
Trial Phases:Phase 4: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Blackmores (Development of next-generation probiotics), Hudson Institute (Microbiome research partnership)
COMPETITION
Position:Emerging
Competitors:Seres Therapeutics, MaaT Pharma, Vedanta Biosciences, Finch Therapeutics
LEADERSHIP
Key Executives:
Sam Costello - CEO & Co-Founder
Rob Bryant - Co-Founder
Scientific Founders:Sam Costello, Rob Bryant, Sam Forster, Emily Tucker
LINKS
Website:biomebank.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with BiomeBank. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.